Published in Qual Life Res on May 28, 2008
Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst (2014) 1.42
Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. BJU Int (2010) 0.86
A longitudinal study of the role of patient-reported outcomes on survival prediction of palliative cancer inpatients in Taiwan. Support Care Cancer (2009) 0.78
Controversies on individualized prostate cancer care: gaps in current practice. Ther Adv Urol (2013) 0.76
The impact of disease progression on perceived health status and quality of life of long-term cancer survivors. J Cancer Surviv (2009) 0.75
Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study. BMJ Open (2014) 0.75
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA (1998) 21.31
Can comorbidity be measured by questionnaire rather than medical record review? Med Care (1996) 10.53
The RAND 36-Item Health Survey 1.0. Health Econ (1993) 10.05
Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA (2000) 6.37
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol (2007) 5.12
The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care (1998) 4.34
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst (2005) 3.26
The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology (1996) 3.26
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer (2007) 2.64
Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst (2001) 2.09
Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol (2001) 2.00
Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys (1999) 1.89
Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study. Med Care (2005) 1.71
Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice. Cancer (2007) 1.68
Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol (2004) 1.52
Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol (2003) 1.51
Development and testing of a new measure of case mix for use in office practice. Med Care (1995) 1.45
Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer. Urology (1999) 1.30
Cancer survivorship: the interface of aging, comorbidity, and quality care. J Natl Cancer Inst (2006) 1.28
Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol (2005) 1.19
Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.14
On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol (2007) 1.14
Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer (2002) 1.00
Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology (2006) 0.94
Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology (2006) 0.89
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst (2007) 5.69
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol (2002) 4.13
Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol (2003) 4.11
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer (2008) 3.14
Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14
Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst (2002) 3.00
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74
Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst (2004) 2.66
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Spirituality influences health related quality of life in men with prostate cancer. Psychooncology (2006) 2.65
Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer (2010) 2.61
Androgen deprivation therapy and cardiovascular risk. J Clin Oncol (2011) 2.55
Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol (2003) 2.44
Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41
Diffusion of surgical innovation among patients with kidney cancer. Cancer (2008) 2.38
Prostate cancer severity among low income, uninsured men. J Urol (2008) 2.38
Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst (2009) 2.28
Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst (2010) 2.17
Comorbidity and competing risks for mortality in men with prostate cancer. Cancer (2011) 2.17
Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology (2009) 2.16
Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer (2007) 2.13
Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer (2014) 2.07
Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer (2014) 2.06
Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05
The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol (2006) 2.02
Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol (2011) 1.97
Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer (2009) 1.95
Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology (2002) 1.90
Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer (2008) 1.89
Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87
Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst (2013) 1.86
Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol (2012) 1.84
Correlates of bother following treatment for clinically localized prostate cancer. J Urol (2010) 1.82
Variation in continence and potency by definition. J Urol (2003) 1.75
Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73
Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol (2009) 1.72
Variations in reconstruction after radical cystectomy. Cancer (2006) 1.69
Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med (2011) 1.69
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer (2004) 1.64
Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer (2010) 1.63
The demographic burden of urologic diseases in America. Urol Clin North Am (2009) 1.61
Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol (2010) 1.60
Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol (2011) 1.59
Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med (2010) 1.59
Cumulative cost pattern comparison of prostate cancer treatments. Cancer (2007) 1.57
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology (2005) 1.57
Emergency department revisits for patients with kidney stones in California. Acad Emerg Med (2015) 1.56
Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol (2007) 1.56
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer (2014) 1.55
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol (2004) 1.52
Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer (2013) 1.51
Health related quality of life in men with prostate cancer. J Urol (2003) 1.51
Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol (2005) 1.50
Trends in the surgical management of stress urinary incontinence among female Medicare beneficiaries, 2002-2007. Urology (2013) 1.49
Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49
Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology (2011) 1.48
The effect of concomitant prolapse repair on sling outcomes. J Urol (2008) 1.47
Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med (2010) 1.45
A survey of primary care physician practices in the diagnosis and management of women with interstitial cystitis/painful bladder syndrome. Urology (2010) 1.42
Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol (2007) 1.41
Improving decisions for men with prostate cancer: translational outcomes research. J Urol (2010) 1.41
Patterns of care in testicular torsion: influence of hospital transfer on testicular outcomes. J Pediatr Urol (2013) 1.41
Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries. Urology (2009) 1.41
External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res (2009) 1.40
Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer (2007) 1.37
The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey. J Urol (2006) 1.36
Regret in men treated for localized prostate cancer. J Urol (2003) 1.35
The effect of age on outcomes of sling surgery for urinary incontinence. J Am Geriatr Soc (2007) 1.34
Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol (2006) 1.31
Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol (2011) 1.31
Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol (2008) 1.29